Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure
Recruiting · NCT07161271 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hong Kong University
View the official record on ClinicalTrials.gov →What this trial is about
This is an observational study performed by retrospective review of data routinely collected for patients receiving low-flow extracorporeal carbon dioxide removal (ECCO2R) therapy in intensive care units (ICUs). Our aim is to firstly, describe the local practice in terms of patient selection and technical details of clinical management related to the use of low-flow ECCO2R system, and secondly, the clinical results in terms of patient outcomes and adverse events. These findings may allow clinicians to improve the quality and safety of ECCO2R therapy provision in the ICU.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients supported with ECCO2R in one of the designated study sites
- Admitted to the ICU between 1 Jan 2022 and 30 June 2024
Exclusion criteria
- Patients younger than 18 years old
Where it is running
1 location listed.
- Queen Mary Hospital (QMH) - Hong Kong, Hong Kong